A novel bladder cancer surveillance schedule using bladder Cx for patients on annual surveillance
Abstract Objectives Cx bladder monitor (CxM) is a urine test with a proven high sensitivity and negative predictive value in bladder cancer surveillance. The aim of this retrospective study was to report on the outcomes of our newly implemented bladder cancer surveillance program for patients eligib...
Saved in:
Main Authors: | Arjun Guduguntla, Thomas Whish‐Wilson, Lauren Chandler, Dennis Gyomber |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | BJUI Compass |
Subjects: | |
Online Access: | https://doi.org/10.1002/bco2.468 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current capabilities of endoscopic diagnosis of non-muscle invasive bladder cancer
by: I. N. Zaborskii, et al.
Published: (2020-06-01) -
Effects of Different Voided Urine Sample Storage Time, Temperature, and Preservatives on Analysis with Multiplex Bead-Based Oncuria Bladder Cancer Immunoassay
by: Sunao Tanaka, et al.
Published: (2025-01-01) -
Bibliometric analysis of photodynamic research in bladder cancer: Trends and future directions
by: Xi Xu, et al.
Published: (2025-04-01) -
The significance of isolated de novo red patches in the bladder in patients referred with suspected urinary tract cancer: Results from the IDENTIFY study
by: Sinan Khadhouri, et al.
Published: (2025-01-01) -
A model of thermotherapy treatment for bladder cancer
by: Christoph Sadée, et al.
Published: (2016-07-01)